35.95
+3.19%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Progyny
From its filings with the US Securities and Exchange Commission
Progyny is based in New York, New York and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker PGNY. The SEC classifies its business as misc health & allied services, nec. In the fiscal year to 31 December 2025, it reported revenue of $1.29bn and net income of $58.5m. At that date it held total assets of $742.4m and shareholders' equity of $516.0m. By business, Fertility benefit services revenue brought in 64.5% of revenue, followed by Pharmacy benefit services revenue at 35.5%.
Progyny is a global leader in women’s health and family building solutions. We envision a world where everyone can realize their dreams of family and ideal health. Our mission is to empower healthier, supported journeys through transformative fertility, family building and women’s health benefits. Through our differentiated approach to benefits plan design, member education and support and active network management, our clients’ employees are able to pursue the most effective treatment across life’s milestones from the best providers and specialists and achieve optimal outcomes.
We are transforming women’s health benefits, proving that comprehensive, inclusive, and intentionally designed solutions can simultaneously benefit employers, members and providers. We believe the value proposition we deliver to all of these constituents is key to our success and growth. Our solutions empower members with concierge support, coaching, education, and digital tools; provide access to a premier network of fertility and women’s health specialists who use the latest science and technologies; drive optimal clinical outcomes; and reduce healthcare costs.
Quoted from its 10-K, filed 27 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 25 Oct 2019
- Employees
- 835
- Website
- progyny.com ↗
- Head office
- 1359 BROADWAY, NEW YORK, NY, 10018
- Incorporated in
- DE
- Classification
- Services-Misc Health & Allied Services, NEC
- Filer status
- Large accelerated filer
Leadership
Pay as last reported
- Mr. David SchlangerExecutive Chairman of the Board, since 2017$468,168
- Mr. Michael SturmerPresident$21.5m
- Mr. Peter AnevskiChief Executive Officer, Director, since 2017$1.4m
- Mr. Mark LivingstonChief Financial Officer$2.1m
- Ms. Melissa CummingsChief Operating Officer
- Ms. Allison SwartzExecutive Vice President, General Counsel, Secretary$1.9m
- Mr. Geoffrey ClappChief Product Officer
- Mr. Jeffrey ParkLead Independent Director$609,386
- Mr. Lloyd DeanIndependent Director$518,326
- Mr. Kevin GordonIndependent Director$518,326
- Mr. Roger HolsteinIndependent Director$518,326
- Ms. Debra MorrisIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 31
- Environment
- 10
- Social
- 53
- Governance
- 31
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Progyny Inc has established itself as a leader in the fertility benefits management industry, providing comprehensive solutions for employers and patients alike. The company's strengths lie in:
Weaknesses
- While Progyny Inc has several strengths, there are some areas where the company can improve:
Opportunities
- Progyny Inc can capitalize on various opportunities in the fertility benefits management sector:
Threats
- As with any business, Progyny Inc faces certain threats that could impact its operations:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.